Aprea Therapeutics Inc. (APRE) NASDAQ

$4.12 0.30 (7.85%)

Market Cap: $88.44M

As of 12/08/21 04:00 PM EST. Market closed.

(APRE)

Aprea Therapeutics Inc. (APRE) NASDAQ

$4.12 0.30 (7.85%)

Market Cap: $88.44M

As of 12/08/21 04:00 PM EST. Market closed.

Aprea Therapeutics, Inc. is a biopharmaceutical company headquartered in Boston, Massachusetts with research facilities in Stockholm, Sweden, focused on developing and commercializing novel cancer therapeutics that reactivate mutant tumor suppressor protein, p53. The Company's lead product candidate is eprenetapopt (APR-246), a small molecule in clinical development for hematologic malignancies, ... read more

Aprea Therapeutics, Inc. is a biopharmaceutical company headquartered in Boston, Massachusetts with research facilities in Stockholm, Sweden, focused on developing and commercializing novel cancer therapeutics that reactivate mutant tumor suppressor protein, p53. The Company's lead product candidate is eprenetapopt (APR-246), a small molecule in clinical development for hematologic malignancies, including myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML). Eprenetapopt has received Breakthrough Therapy, Orphan Drug and Fast Track designations from the FDA for MDS, Fast Track designation from the FDA for AML, and Orphan Drug designation from the European Commission for MDS, AML and ovarian cancer. APR-548, a next generation small molecule reactivator of mutant p53, is being developed for oral administration. read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
URL
Address
.
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
Full Time Employees
17
URL
Address
.
KEY STATS
Open
$4.79
Previous Close
$3.82
Days Range
$3.85 - $4.32
52 week range
$3.17 - $30.28
Volume
1,067,849
Avg. Volume (30 days)
683,462
Market Cap
$88.44M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
21,465,140
Open
$4.79
Previous Close
$3.82
Days Range
$3.85 - $4.32
52 week range
$3.17 - $30.28
Volume
1,067,849
Avg. Volume (30 days)
683,462
Market Cap
$88.44M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
21,465,140

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR APREA THERAPEUTICS INC
Owner Relationship Date Transaction Cost # Shares Value($) Total Shares Form 4
Korbel Gregory Alan SVP, Chief Business Officer Dec 01, 2021 Option Exercise $0.92 27,500 25,300 44,667 Dec 03, 2021, 05:01 PM
Korbel Gregory Alan SVP, Chief Business Officer Dec 01, 2021 Sale $3.96 27,500 108,900 17,167 Dec 03, 2021, 05:01 PM
Korbel Gregory Alan SVP, Chief Business Officer Nov 01, 2021 Option Exercise $0.92 27,500 25,300 44,667 Nov 03, 2021, 05:34 PM
Korbel Gregory Alan SVP, Chief Business Officer Nov 01, 2021 Sale $5.00 27,500 137,500 17,167 Nov 03, 2021, 05:34 PM
Abrahmsen Lars B. SVP, Chief Scientific Officer Oct 01, 2021 Option Exercise $0.92 50,000 46,000 69,000 Oct 05, 2021, 05:01 PM
Abrahmsen Lars B. SVP, Chief Scientific Officer Oct 01, 2021 Sale $4.89 50,000 244,500 19,000 Oct 05, 2021, 05:01 PM
Korbel Gregory Alan SVP, Chief Business Officer Oct 01, 2021 Option Exercise $0.92 27,500 25,300 44,667 Oct 05, 2021, 05:01 PM
Korbel Gregory Alan SVP, Chief Business Officer Oct 01, 2021 Sale $4.89 27,500 134,475 17,167 Oct 05, 2021, 05:01 PM
Korbel Gregory Alan SVP, Chief Business Officer Sep 20, 2021 Option Exercise $0.92 27,500 25,300 44,667 Sep 22, 2021, 05:01 PM
Korbel Gregory Alan SVP, Chief Business Officer Sep 20, 2021 Sale $4.97 32,960 163,866 17,167 Sep 22, 2021, 05:01 PM
Abrahmsen Lars B. SVP, Chief Scientific Officer Sep 20, 2021 Option Exercise $0.92 25,000 23,000 44,000 Sep 22, 2021, 05:00 PM
Abrahmsen Lars B. SVP, Chief Scientific Officer Sep 20, 2021 Sale $4.97 25,000 124,250 19,000 Sep 22, 2021, 05:00 PM
Attar Eyal C. SVP, Chief Medical Officer Sep 16, 2021 Sale $4.68 15,968 74,730 83,000 Sep 20, 2021, 05:29 PM
Korbel Gregory Alan Chief Business Officer Sep 10, 2021 Option Exercise $4.59 1,724 7,913 22,627 Sep 14, 2021, 05:01 PM
Korbel Gregory Alan Chief Business Officer Aug 25, 2021 Option Exercise $3.98 1,149 4,573 24,351 Aug 27, 2021, 05:02 PM
Coiante Scott M SVP, Chief Financial Officer Aug 25, 2021 Option Exercise $3.98 7,534 29,985 91,466 Aug 27, 2021, 05:01 PM
Attar Eyal C. SVP, Chief Medical Officer Aug 25, 2021 Option Exercise $3.98 9,032 35,947 98,968 Aug 27, 2021, 05:00 PM
Redmile Group, LLC 10% Owner Dec 28, 2020 Sale $5.58 500,000 2,791,290 1,774,581 Feb 16, 2021, 04:11 PM
5AM Ventures IV, L.P. Former 10% holder Oct 05, 2020 Sale $25.30 175,000 4,427,500 138,497 Oct 07, 2020, 09:30 PM
KDev Investments AB 10% Owner Jul 07, 2020 Sale $34.55 241,703 8,350,838 1,992,586 Jul 07, 2020, 05:41 PM
ROCKLAGE SCOTT M Director Jun 16, 2020 Sale $33.30 120,164 4,001,461 1,823,192 Jun 18, 2020, 07:23 PM
5AM Ventures IV, L.P. 10% Owner Jun 16, 2020 Sale $33.30 140,000 4,662,000 1,823,192 Jun 18, 2020, 07:22 PM
ROCKLAGE SCOTT M Director Jun 11, 2020 Sale $28.75 245,000 7,044,412 1,938,549 Jun 15, 2020, 09:13 PM
5AM Ventures IV, L.P. 10% Owner Jun 11, 2020 Sale $28.75 245,000 7,044,412 1,938,549 Jun 15, 2020, 09:12 PM
ROCKLAGE SCOTT M Director May 19, 2020 Sale $35.15 255,000 8,963,250 2,173,748 May 21, 2020, 09:32 PM
5AM Ventures IV, L.P. 10% Owner May 19, 2020 Sale $35.15 255,000 8,963,250 2,173,748 May 21, 2020, 09:31 PM
KDev Investments AB 10% Owner Apr 13, 2020 Sale $31.25 210,548 6,579,625 2,234,289 Apr 15, 2020, 09:18 AM
5AM Ventures IV, L.P. 10% Owner Oct 07, 2019 Buy $15.00 333,333 4,999,995 333,333 Oct 09, 2019, 06:23 PM
Redmile Group, LLC 10% Owner Oct 07, 2019 Buy $15.00 400,000 6,000,000 2,268,718 Oct 08, 2019, 08:13 PM
HealthCap VII, L.P. 10% Owner Oct 07, 2019 Buy $15.00 266,667 4,000,005 2,366,104 Oct 07, 2019, 07:53 PM
Versant Vantage I, L.P. 10% Owner Oct 07, 2019 Buy $15.00 333,333 4,999,995 333,333 Oct 07, 2019, 07:40 PM
Versant V Luxco S.a r.l. 10% Owner Oct 07, 2019 Buy $15.00 333,333 4,999,995 333,333 Oct 07, 2019, 07:39 PM
Christenson Johan Director Oct 07, 2019 Buy $15.00 266,667 4,000,005 2,366,104 Oct 07, 2019, 07:33 PM
Seizinger Bernd R. Director Oct 07, 2019 Option Exercise $0.07 263,970 18,478 263,970 Oct 07, 2019, 07:33 PM
Magni Guido Director Oct 07, 2019 Buy $15.00 6,500 97,500 6,500 Oct 07, 2019, 07:25 PM
HENNEMAN JOHN B III Director Oct 07, 2019 Buy $15.00 5,000 75,000 5,000 Oct 07, 2019, 07:23 PM
Korbel Gregory Alan VP of Business Dev't Oct 07, 2019 Buy $15.00 500 7,500 500 Oct 07, 2019, 07:21 PM
Attar Eyal C. SVP, Chief Medical Officer Oct 07, 2019 Buy $15.00 200 3,000 200 Oct 07, 2019, 07:18 PM
Attar Eyal C. SVP, Chief Medical Officer Oct 07, 2019 Buy $15.00 200 3,000 200 Oct 07, 2019, 07:18 PM
Coiante Scott M SVP, Chief Financial Officer Oct 07, 2019 Buy $15.00 2,500 37,500 2,500 Oct 07, 2019, 07:15 PM
SCHADE CHRISTIAN S President & CEO Oct 07, 2019 Buy $15.00 6,000 90,000 1,000 Oct 07, 2019, 07:15 PM
SCHADE CHRISTIAN S President & CEO Oct 07, 2019 Buy $15.00 5,000 75,000 5,000 Oct 07, 2019, 07:15 PM
Load More Insider Transactions
Buy Sale Option Exercise
Owner Relationship Date Value($)
Korbel Gregory Alan SVP, Chief Business Officer 12/01/2021 25,300
Korbel Gregory Alan SVP, Chief Business Officer 12/01/2021 108,900
Korbel Gregory Alan SVP, Chief Business Officer 11/01/2021 25,300
Korbel Gregory Alan SVP, Chief Business Officer 11/01/2021 137,500
Abrahmsen Lars B. SVP, Chief Scientific Officer 10/01/2021 46,000
Abrahmsen Lars B. SVP, Chief Scientific Officer 10/01/2021 244,500
Korbel Gregory Alan SVP, Chief Business Officer 10/01/2021 25,300
Korbel Gregory Alan SVP, Chief Business Officer 10/01/2021 134,475
Korbel Gregory Alan SVP, Chief Business Officer 09/20/2021 25,300
Korbel Gregory Alan SVP, Chief Business Officer 09/20/2021 163,866
Abrahmsen Lars B. SVP, Chief Scientific Officer 09/20/2021 23,000
Abrahmsen Lars B. SVP, Chief Scientific Officer 09/20/2021 124,250
Attar Eyal C. SVP, Chief Medical Officer 09/16/2021 74,730
Korbel Gregory Alan Chief Business Officer 09/10/2021 7,913
Korbel Gregory Alan Chief Business Officer 08/25/2021 4,573
Coiante Scott M SVP, Chief Financial Officer 08/25/2021 29,985
Attar Eyal C. SVP, Chief Medical Officer 08/25/2021 35,947
Redmile Group, LLC 10% Owner 12/28/2020 2,791,290
5AM Ventures IV, L.P. Former 10% holder 10/05/2020 4,427,500
KDev Investments AB 10% Owner 07/07/2020 8,350,838
ROCKLAGE SCOTT M Director 06/16/2020 4,001,461
5AM Ventures IV, L.P. 10% Owner 06/16/2020 4,662,000
ROCKLAGE SCOTT M Director 06/11/2020 7,044,412
5AM Ventures IV, L.P. 10% Owner 06/11/2020 7,044,412
ROCKLAGE SCOTT M Director 05/19/2020 8,963,250
5AM Ventures IV, L.P. 10% Owner 05/19/2020 8,963,250
KDev Investments AB 10% Owner 04/13/2020 6,579,625
5AM Ventures IV, L.P. 10% Owner 10/07/2019 4,999,995
Redmile Group, LLC 10% Owner 10/07/2019 6,000,000
HealthCap VII, L.P. 10% Owner 10/07/2019 4,000,005
Versant Vantage I, L.P. 10% Owner 10/07/2019 4,999,995
Versant V Luxco S.a r.l. 10% Owner 10/07/2019 4,999,995
Christenson Johan Director 10/07/2019 4,000,005
Seizinger Bernd R. Director 10/07/2019 18,478
Magni Guido Director 10/07/2019 97,500
HENNEMAN JOHN B III Director 10/07/2019 75,000
Korbel Gregory Alan VP of Business Dev't 10/07/2019 7,500
Attar Eyal C. SVP, Chief Medical Officer 10/07/2019 3,000
Attar Eyal C. SVP, Chief Medical Officer 10/07/2019 3,000
Coiante Scott M SVP, Chief Financial Officer 10/07/2019 37,500
SCHADE CHRISTIAN S President & CEO 10/07/2019 90,000
SCHADE CHRISTIAN S President & CEO 10/07/2019 75,000
Load More Insider Transactions